UROBAK Drug Patent Profile
Which patents cover Urobak, and when can generic versions of Urobak launch?
Urobak is a drug marketed by Shionogi and is included in one NDA.
The generic ingredient in UROBAK is sulfamethoxazole. There is one drug master file entry for this compound. Additional details are available on the sulfamethoxazole profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for UROBAK?
- What are the global sales for UROBAK?
- What is Average Wholesale Price for UROBAK?
Summary for UROBAK
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 155 |
| Patent Applications: | 4,552 |
| DailyMed Link: | UROBAK at DailyMed |
US Patents and Regulatory Information for UROBAK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shionogi | UROBAK | sulfamethoxazole | TABLET;ORAL | 087307-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
